U.S. Food and Drug Commissioner Scott Gottlieb attends an interview at Reuters headquarters in New York City, U.S., October 10, 2017. REUTERS/Eduardo Munoz By Nate Raymond BOSTON (Reuters) - The U.S.
The U.S. Food and Drug Administration and a trade group that represents large compound pharmacies have resolved a long-running dispute over the use of bulk ingredients, clearing the way for some ...
GLP-1 medications have changed the conversation around weight management and metabolic health. When prescribed appropriately, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results